Ifosfamide is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Ifosfamide.
| Product ID | 63323-142_94929aec-97bb-7741-e053-2995a90ac45d |
| NDC | 63323-142 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ifosfamide |
| Generic Name | Ifosfamide |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2003-01-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA076078 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | IFOSFAMIDE |
| Active Ingredient Strength | 1 g/1 |
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2003-01-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA076078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-01-28 |
| Marketing Category | ANDA |
| Application Number | ANDA076078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-01-28 |
| Ingredient | Strength |
|---|---|
| IFOSFAMIDE | 1 g/1 |
| SPL SET ID: | a311a947-7b78-4226-bfe0-f4aa0be20e27 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9530 | Ifosfamide | Ifosfamide |
| 0143-9531 | Ifosfamide | Ifosfamide |
| 0703-3427 | Ifosfamide | Ifosfamide |
| 0703-3429 | Ifosfamide | Ifosfamide |
| 10019-925 | IFOSFAMIDE | IFOSFAMIDE |
| 10019-926 | IFOSFAMIDE | IFOSFAMIDE |
| 10019-927 | IFOSFAMIDE | ifosfamide |
| 10019-929 | IFOSFAMIDE | ifosfamide |
| 63323-142 | Ifosfamide | IFOSFAMIDE |
| 0338-3991 | IFEX | ifosfamide |
| 0338-3993 | IFEX | ifosfamide |